Genomic analysis has the potential to revolutionize the field of healthcare, particularly in the early detection and management of cardiovascular diseases (CVDs). This article provides an overview of the role of genomic analysis in CVD detection, including its ability to identify genetic markers associated with CVDs, enable early detection, and potentially lead to personalized treatment. We also discuss the limitations and challenges of genomic analysis in CVD detection, such as cost and data interpretation, and ongoing research efforts to address these issues. Additionally, we highlight the potential future implications of genomic analysis in CVD detection, such as its use in risk prediction and prevention strategies